Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Healthcare | 15.49% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
NCS Multistage Holdings
NCSM
$124M
| $9.41M | 0.01% |
28,486
+6
| +0% | +$1.9K |
|
|
NBLX
477
DELISTED
Noble Midstream Partners LP
NBLX
| $9.24M | 0.01% |
260,895
-27,270
| -9% | -$1.27M |
|
478
Cogent Biosciences
COGT
$6.64B
| $9.17M | 0.01% |
222,508
-11,319
| -5% | -$638K |
|
|
CEQP
479
DELISTED
Crestwood Equity Partners LP
CEQP
| $9.07M | 0.01% |
+246,757
| New | +$9.02M |
|
|
KA
480
DELISTED
Kineta, Inc. Common Stock
KA
| $8.89M | 0.01% |
26,358
+189
| +0.7% | +$67.4K |
|
481
Select Water Solutions
WTTR
$2.29B
| $8.74M | 0.01% |
738,572
-2,045
| -0.3% | -$28.1K |
|
|
ICD
482
DELISTED
Independence Contract Drilling, Inc.
ICD
| $8.69M | 0.01% |
87,932
-38
| -0% | -$3.15K |
|
483
Heritage Financial
HFWA
$1.23B
| $8.46M | 0.01% |
240,777
-2,383
| -1% | -$85.6K |
|
484
Neuronetics
STIM
$150M
| $8.22M | 0.01% |
256,532
-68,243
| -21% | -$2.07M |
|
|
FSTX
485
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $8.21M | 0.01% |
+170,333
| New | +$8.53M |
|
486
Wheaton Precious Metals
WPM
$50.8B
| $7.84M | 0.01% |
447,863
-32,790
| -7% | -$629K |
|
487
Teck Resources
TECK
$29.5B
| $7.72M | 0.01% |
+320,223
| New | +$7.7M |
|
|
ENLC
488
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $7.54M | 0.01% |
458,454
+20,784
| +5% | +$346K |
|
489
Warrior Met Coal
HCC
$4.25B
| $7.51M | 0.01% |
277,851
-121,359
| -30% | -$3.1M |
|
490
Hudbay
HBM
$10.4B
| $7.42M | 0.01% |
1,465,454
-137,468
| -9% | -$681K |
|
491
Heron Therapeutics
HRTX
$96.8M
| $7.19M | 0.01% |
227,051
+2,051
| +0.9% | +$76.4K |
|
492
Reliance Steel & Aluminium
RS
$20.9B
| $6.47M | 0.01% |
75,846
-53,400
| -41% | -$4.73M |
|
493
USA Compression Partners
USAC
$3.73B
| $6.35M | 0.01% |
384,594
+15,656
| +4% | +$264K |
|
494
Eastman Chemical
EMN
$8.23B
| $6.31M | 0.01% |
65,958
-8,331
| -11% | -$826K |
|
495
Quanterix
QTRX
$175M
| $6.3M | 0.01% |
294,314
-57,517
| -16% | -$909K |
|
|
WCN
496
Waste Connections
WCN
$42.3B
| $5.67M | 0.01% |
+71,047
| New | +$5.58M |
|
|
EQGP
497
DELISTED
EQGP Holdings, LP
EQGP
| $5.55M | 0.01% |
266,374
+11,410
| +4% | +$255K |
|
498
Antero Midstream
AM
$10.4B
| $5.54M | 0.01% |
327,155
+14,314
| +5% | +$262K |
|
499
iShares Russell 1000 Growth ETF
IWF
$124B
| $5.17M | ﹤0.01% |
132,596
-98,220
| -43% | -$3.72M |
|
500
Fate Therapeutics
FATE
$291M
| $4.89M | ﹤0.01% |
+300,000
| New | +$3.55M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.